Cargando…
Microfluidic Thrombosis under Multiple Shear Rates and Antiplatelet Therapy Doses
The mainstay of treatment for thrombosis, the formation of occlusive platelet aggregates that often lead to heart attack and stroke, is antiplatelet therapy. Antiplatelet therapy dosing and resistance are poorly understood, leading to potential incorrect and ineffective dosing. Shear rate is also su...
Autores principales: | Li, Melissa, Hotaling, Nathan A., Ku, David N., Forest, Craig R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880267/ https://www.ncbi.nlm.nih.gov/pubmed/24404131 http://dx.doi.org/10.1371/journal.pone.0082493 |
Ejemplares similares
-
Protease‐activated receptor antagonists prevent thrombosis when dual antiplatelet therapy is insufficient in an occlusive thrombosis microfluidic model
por: Berry, Jess, et al.
Publicado: (2022) -
Role of insulin-like growth factor 1 in stent thrombosis under effective dual antiplatelet therapy
por: Yalcin, Ahmet Arif, et al.
Publicado: (2014) -
Cells Under Stress: An Inertial-Shear Microfluidic Determination of Cell Behavior
por: Armistead, Fern J., et al.
Publicado: (2019) -
Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
por: Brunetti, Natale Daniele, et al.
Publicado: (2019) -
Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk
por: Ting, Lucas H., et al.
Publicado: (2019)